Company: BAYAU
Filing Date: 2025-04-01
Form Type: 10-K
Source: 0001641172-25-002125
Chunk: 224

Company: Bayview Acquisition Corp
Filing Date: 2025-04-01
Form: 10-K
Item: Item 1A
Chunk 224
---
Our
Private Placement Units and Founder Shares may have an adverse effect on the market price of our Ordinary Shares and make it more difficult
to complete our business combination.

Simultaneously
with the closing of the IPO, we issued 232,500 Private Placement Units to our Sponsors. Our founders currently own 1,500,000 Founder
Shares (up to 225,000 Founder Shares were forfeited because the over-allotment option was not exercised in full or in part). In addition,
if our founders or their affiliates make any working capital loans, up to $300,000 of such loans may be converted into working capital
units, at the price of $10.00 per unit at the option of the lender. Such working capital units would be identical to the Private Placement
Units sold in the private placement.

To
the extent we issue Ordinary Shares to complete a business combination, the potential for the issuance of a substantial number of additional
Ordinary Shares upon conversion rights of up to $300,000 working capital loans could make us a less attractive acquisition vehicle to
a target business. Any such issuance will increase the number of issued and outstanding Ordinary Shares and reduce the value of the Ordinary
Shares issued to complete the business combination. Therefore, our Private Placement Units and Founder Shares may make it more difficult
to complete a business combination or increase the cost of acquiring the target business.

  29 

We
may amend the terms of the Rights in a manner that may be adverse to holders of public rights with the approval by the holders of at
least 50% of the then outstanding public rights.

Our
Rights were issued in registered form under a rights agreement and between Equiniti Trust Company, LLC, as rights agent, and us. The
rights agreement provides that the terms of the Rights may be amended without the consent of any holder to cure any ambiguity or correct
any defective provision, but requires the approval by the holders of at least 50% of the then outstanding public rights to make any change
that adversely affects the interests of the registered holders of public rights. Accordingly, we may amend the terms of the public rights
in a manner adverse to a holder if holders of at least 50% of the then outstanding public rights approve of such amendment.

The
determination of the offering price of our Units and the size of the IPO is more arbitrary than the pricing of securities and size of
an offering of an operating company in a particular industry. You may have less assurance, therefore,